Polyphophazenes as anti-cancer drug carriers: From synthesis to application

被引：33

作者：

Akram, Muhammad ^{[1
]}

Wang, Li ^{[1
]}

Yu, Haojie ^{[1
]}

Amer, Wael A. ^{[1
]}

Khalid, Hamad ^{[1
]}

Abbasi, Nasir M. ^{[1
]}

Chen, Yongsheng ^{[1
]}

Saleem, Zain-ul-Abdin M. ^{[1
]}

Tong, Rongbai ^{[1
]}

机构：

[1] Zhejiang Univ, Dept Chem & Biol Engn, State Key Lab Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China

来源：

PROGRESS IN POLYMER SCIENCE | 2014年 / 39卷 / 12期

基金：

中国国家自然科学基金;

关键词：

Anti-cancer drug; Poly(organophosphazene); pH-responsiveness; Drug delivery system; LIVING CATIONIC-POLYMERIZATION; HIGH-MOLECULAR-WEIGHT; AMBIENT-TEMPERATURE POLYMERIZATION; RECENT RESEARCH PROGRESS; IN-VITRO CYTOTOXICITY; CONTROLLED-RELEASE; AMPHIPHILIC POLYPHOSPHAZENES; PHOSPHONITRILIC COMPOUNDS; MULTIDRUG-RESISTANCE; CLINICAL-EXPERIENCE;

D O I：

10.1016/j.progpolymsci.2014.07.009

中图分类号：

O63 [高分子化学（高聚物）];

学科分类号：

070305 ; 080501 ; 081704 ;

摘要：

Currently, most of administered anti-cancer drugs are low molecular weight compounds (as compare to polymers) and hydrophobic in nature. Such small molecular anti-cancer drugs possess fast clearance rate from the blood circulating system and have toxic side effects. Poly(organophosphazenes) have wide range of biomedical applications owing good biocompatibility, sustainability and degradability into non-toxic by-products. So, in this review, we have carefully selected such poly(organophosphazenes), which proved to be good anti-cancer drug carriers because of overcoming crucial issues related to the administration of anti-cancer drugs i.e. poor hydrophilicity, lack of cancer cells specificity, and fast clearance rate from blood circulating system. Thence, the main focus of this review is to highlight the advancement that have been achieved in the synthesis of poly(organophosphazenes) and their application in anti-cancer drug delivery system (DDS). (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：1987 / 2009

页数：23

共 50 条

[21] Synthesis of potent GST inhibitors to overcome anti-cancer drug resistance
Janser, Ingo
Zayed, Asil
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[22] Synthesis of malformin C and analogs for targeted anti-cancer drug delivery
Hossain, Farzana
Nishat, Sharmeen
Andreana, Peter
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
[23] Biocompatible, pH-responsive, and biodegradable polyurethanes as smart anti-cancer drug delivery carriers
Shoaib, Muhammad
Bahadur, Ali
Saeed, Aamer
Rahman, Muhammad Saif Ur
Naseer, Muhammad Moazzam
REACTIVE & FUNCTIONAL POLYMERS, 2018, 127 : 153 - 160
[24] In vivo evaluation of poly-L-asparagine nanocapsules as carriers for anti-cancer drug delivery
Rivera-Rodriguez, Gustavo R.
Lollo, Giovanna
Montier, Tristan
Benoit, Jean Pierre
Passirani, Catherine
Jose Alonso, Maria
Torres, Dolores
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 458 (01) : 83 - 89
[25] Anti-Cancer Drug Delivery System
Li Yan
Huang Wei
Huang Ping
Zhu Xinyuan
Yan Deyue
PROGRESS IN CHEMISTRY, 2014, 26 (08) : 1395 - 1408
[26] Valproic acid as anti-cancer drug
Michaelis, Martin
Doerr, Hans Wilhelm
Cinatl, Jindrich, Jr.
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (33) : 3378 - 3393
[27] MACROMOLECULE ANTI-CANCER DRUG CONJUGATES
KATO, Y
HARA, T
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1983, 41 (12) : 1135 - 1142
[28] Mitosis as an anti-cancer drug target
Anna-Leena Salmela
Marko J. Kallio
Chromosoma, 2013, 122 : 431 - 449
[29] Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
Berdiaki, Aikaterini
Neagu, Monica
Giatagana, Eirini-Maria
Kuskov, Andrey
Tsatsakis, Aristidis M.
Tzanakakis, George N.
Nikitovic, Dragana
BIOMOLECULES, 2021, 11 (03) : 1 - 31
[30] FTORAFUR - NEW ANTI-CANCER DRUG
BRENNER, H
CHAITCHIK, S
BRENNER, J
DIGESTION, 1977, 16 (03) : 233 - 233

← 1 2 3 4 5 →